Skin repair device developer Avita Medical (RCEL.US) Recell GO system receives CE certification from the European Union, prompting a pre-market surge.

According to the financial app Wisdom Finance, Avita Medical, a developer of skin repair devices, has obtained CE certification for its new generation autologous cell collection device RECELL GO system under the EU Medical Device Regulations (EU MDR). Encouraged by this news, as of the time of writing, Avita Medical's stock rose nearly 10% in pre-market trading on Monday.